Germline genetic testing to predict drug response and toxicity in oncology- Reality or fiction?

by Soh, T.I., Yong, W.P.
Published 2014

Systemic therapies for pancreatic cancer - the role of pharmacogenetics

by Soo, R.A., Yong, W.-P., Innocenti, F.
Published 2014

Cyclooxygenase-2 expression: A potential prognostic and predictive marker for high-grade ductal carcinoma in situ of the breast

by Tan, K.-B., Putti, T.C., Yong, W.-P.
Published 2012

Recent progress and clinical importance on pharmacogenetics in cancer therapy

by Soh, T.I.P., Yong, W.P., Innocenti, F.
Published 2014

Identification of gastric cancer biomarkers using 1H nuclear magnetic resonance spectrometry

by Ramachandran G.K., Yong W.P., Yeow C.H.
Published 2018

Clinical pharmacology and pharmacogenetics of gemcitabine

by Wong, A., Soo, R.A., Yong, W.-P., Innocenti, F.
Published 2014

Chemoradiation induces upregulation of immunogenic cell death-related molecules together with increased expression of PD-L1 and galectin-9 in gastric cancer

by Petersen, S. H., Kua, L. F., Nakajima, S., Yong, W. P., Kono, K.
Published 2022

Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy

by Subhash, V.V, Yeo, M.S, Tan, W.L, Yong, W.P
Published 2020

Targeted therapeutics-oriented tumor classification: A paradigm shift

by Quek, T.P.L., Yan, B., Salto-Tellez, M., Yong, W.P.
Published 2012

Potential therapeutic significance of HER-family in esophageal squamous cell carcinoma

by Kono, K., Mimura, K., Fujii, H., Shabbir, A., Yong, W.-P., So, J.
Published 2014

Knockdown of POLA2 increases gemcitabine resistance in lung cancer cells

by Koh, V, Kwan, H.Y, Tan, W.L, Mah, T.L, Yong, W.P
Published 2020

Intraperitoneal chemotherapy for gastric cancer with peritoneal disease: experience from Singapore and Japan

by Kono K., Yong W.-P., Okayama H., Shabbir A., Momma T., Ohki S., Takenoshita S., So J.
Published 2018

Resisting resistance to cancer immunotherapy

by RAGHAV SUNDAR, Lam, W.S.-T., Wang, L.Z., Roudi, R., Yong, W.-P., Syn, N.L.
Published 2021

Resisting resistance to cancer immunotherapy

by Lam, W.S.-T., Wang, L.Z., Roudi, R., Yong, W.-P., Syn, N.L., Sundar, R.
Published 2021

UGT1A6 polymorphisms modulated lung cancer risk in a Chinese population

by Kua, L.-F., Ross, S., Lee, S.-C., Mimura, K., Kono, K., Goh, B.-C., Yong, W.-P.
Published 2014

Rapid determination of gemcitabine and its metabolite in human plasma by LC-MSMS through micro protein precipitation with minimum matrix effect

by Wang, L.-Z., Yong, W.-P., Soo, R.-A., Lee, S.-C., Soong, R., Lee, H.-S., Goh, B.-C.
Published 2014

Clinical Impact of Drug-Drug Interaction Between Aspirin and Prednisolone at a Cancer Center

by Koomanan, N., Ko, Y., Yong, W.-P., Ng, R., Wong, Y.-P., Lim, S.-W., Salim, A., Chan, A.
Published 2014

Combination Therapy with Gossypol Reveals Synergism against Gemcitabine Resistance in Cancer Cells with High BCL-2 Expression

by Wong, F.Y., Liem, N., Xie, C., Yan, F.L., Wong, W.C., Wang, L., Yong, W.-P.
Published 2014

Effects of Hepatic Impairment on the Pharmacokinetics of Everolimus: A Single-Dose, Open-Label, Parallel-Group Study

by Peveling-Oberhag, J., Zeuzem, S., Yong, W.P., Kunz, T., Paquet, T., Bouillaud, E., Urva, S., Anak, O., Sellami, D., Kobalava, Z.
Published 2014

Impact of sample heterogeneity on methylation analysis

by Loh, M., Liem, N., Lim, P.L., Vaithilingam, A., Cheng, C.L., Salto-Tellez, M., Yong, W.P., Soong, R.
Published 2014